Last reviewed · How we verify
AC0058TA
At a glance
| Generic name | AC0058TA |
|---|---|
| Also known as | AC0058, Placebo |
| Sponsor | ACEA Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) (PHASE1)
- Study of AC0058TA in Healthy Male and Female Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |